Evidence map›Paper›PMID 32666470›Full record

ReviewNeurology and therapy2020

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis.

María José Sá, Ricardo Soares Dos Reis, Ayse Altintas, Elisabeth Gulowsen Celius, Claudia Chien, Giancarlo Comi, Francesc Graus, Jan Hillert, Jeremy Hobart, Gulfaraz Khan and 8 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neurology and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Clinical and neuroimaging findings in MOGAD-MRI and OCT.Clinical and experimental immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 16 institutions in 13 countries.

María José SáDepartment of Neurology, Centro Hospitalar Universitário de São João, Alameda Prof. Hernáni Monteiro, Porto, Portugal. mjsa@med.up.pt.
Ricardo Soares Dos ReisDepartment of Neurology, Centro Hospitalar Universitário de São João, Alameda Prof. Hernáni Monteiro, Porto, Portugal. r.soaresdosreis@gmail.com.
Ayse AltintasDepartment of Neurology, School of Medicine, Koç University, Istanbul, Turkey.
Elisabeth Gulowsen CeliusDepartment of Neurology, Oslo University Hospital, Ullevål, Oslo, Norway.
Claudia ChienNeuroCure Clinical Research Center, NeuroCure Cluster of Excellence, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Giancarlo ComiDepartment of Neurology, University Vita-Salute San Raffaele, Milan, Italy.
Francesc GrausDepartment of Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) Hospital Clínic, Barcelona, Spain.
Jan HillertDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Jeremy HobartDepartment of Neurology, University Hospitals Plymouth, Plymouth, UK.
Gulfaraz KhanDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Najib KissaniNeurology Department, Marrakech University Hospital Mohammed VI, Marrakech, Morocco.
Dawn LangdonDepartment of Psychology, Royal Holloway, University of London, London, UK.
Maria Isabel LeiteNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Darin T OkudaDepartment of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX, USA.
Jacqueline PalaceNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Regina María Papais-AlvarengaUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Inês Mendes-PintoInternational Iberian Nanotechnology Laboratory, Braga, Portugal.
Fu-Dong ShiBeijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Hospital de São João · PTUniversity of Oxford · GBCadi Ayyad University · MACapital Medical University · CNCharité - Universitätsmedizin Berlin · DEConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESInternational Iberian Nanotechnology Laboratory · PTKarolinska Institutet · SEKoç University · TRRoyal Holloway University of London · GBSouthwestern Medical Center · USUnited Arab Emirates University · AEUniversidade Federal do Estado do Rio de Janeiro · BRUniversity of Oslo · NOUniversity of Plymouth · GBVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 5th International Porto Congress of Multiple Sclerosis took place between the 14th and 16th of February 2019 in Porto, Portugal. Its intensive programme covered a wide-range of themes-including many of the hot topics, challenges, pitfalls and yet unmet needs in the field of multiple sclerosis (MS)-led by a number of well-acknowledged world experts. This meeting review summarizes the talks that took place during the congress, which focussed on issues in MS as diverse as the development and challenges of progressive MS, epidemiology, differential diagnosis, medical management, molecular research and imaging tools.

Indexed as

Congress reviewDemyelinating diseasesMultiple sclerosisNeurological diseases

Identifiers

PMID32666470
PMCPMC7606370
OpenAlexW3042741865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.